FRANCISCO JAVIER
LÓPEZ LONGO
Investigador hasta 2019
Víctor Manuel
Martínez Taboada
Publicaciones en las que colabora con Víctor Manuel Martínez Taboada (17)
2020
-
Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes
Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86
2019
-
ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts
Rheumatology International
-
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
Reumatologia Clinica, Vol. 15, Núm. 1, pp. 34-42
2018
-
Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort
Arthritis Research and Therapy, Vol. 20, Núm. 1
2017
-
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
Scientific Reports, Vol. 7
-
Juvenile- and adult-onset systemic lupus erythematosus: A comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Clinical and Experimental Rheumatology, Vol. 35, Núm. 6, pp. 1047-1055
-
Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding
Reumatologia Clinica, Vol. 13, Núm. 5, pp. 264-281
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, pp. 40-47
2015
2013
-
Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico
Reumatologia Clinica, Vol. 9, Núm. 5, pp. 281-296
2012
-
Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: The LESIMAB study
Lupus, Vol. 21, Núm. 10, pp. 1063-1076
2008
-
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 625-630